{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:45:17Z","timestamp":1789764317853,"version":"4.0.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100001671","name":"Hereditary Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001671","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000887","name":"Huntington's Disease Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington disease is characterized by progressive neurodegeneration, especially of the striatum, and the presence of polyglutamine huntingtin (HTT) inclusions. Although HTT inclusions are most abundant in the neocortex, their neocortical distribution and density in relation to the extent of CAG repeat expansion in the <jats:italic>HTT<\/jats:italic> gene and striatal pathologic grade have yet to be formally established. We immunohistochemically studied 65 brains with a pathologic diagnosis of Huntington disease to investigate the cortical distributions and densities of HTT inclusions within the calcarine (BA17), precuneus (BA7), motor (BA4) and prefrontal (BA9) cortices; in 39 of these brains, a p62 immunostain was used for comparison. HTT inclusions predominate in the infragranular cortical layers (layers V-VI) and layer III, however, the densities of HTT inclusions across the human cerebral cortex are not uniform but are instead regionally contingent. The density of HTT and p62 inclusions (intranuclear and extranuclear) in layers V-VI increases caudally to rostrally (BA17\u2009&lt;\u2009BA7\u2009&lt;\u2009BA4\u2009&lt;\u2009BA9) with the median burden of HTT inclusions being 38-fold greater in the prefrontal cortex (BA9) than in the calcarine cortex (BA17). Conversely, intranuclear HTT inclusions prevail in the calcarine cortex irrespective of <jats:italic>HTT<\/jats:italic> CAG length. Neocortical HTT inclusion density correlates with CAG repeat expansion, but not with the neuropathologic grade of striatal degeneration (Vonsattel grade) or with the duration of clinical disease since motor onset. Extrapolation of these findings suggest that HTT inclusions are at a regionally-contingent, CAG-dependent, density during the advanced stages of HD. The distribution and density of HTT inclusions in HD therefore does not provide a measure of pathologic disease stage but rather infers the degree of pathogenic <jats:italic>HTT<\/jats:italic> expansion.<\/jats:p>","DOI":"10.1186\/s40478-022-01364-1","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T12:04:06Z","timestamp":1650369846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade"],"prefix":"10.1186","volume":"10","author":[{"given":"Richard A.","family":"Hickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis L.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Vonsattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"1364_CR1","unstructured":"Comparing slopes and intercepts https:\/\/www.graphpad.com\/guides\/prism\/7\/curve-fitting\/reg_comparingslopesandintercepts.htm"},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805\u2013810. https:\/\/doi.org\/10.1038\/nature02998","journal-title":"Nature"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","volume":"4","author":"MW Becher","year":"1998","unstructured":"Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA (1998) Intranuclear neuronal inclusions in Huntington\u2019s disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 4:387\u2013397. https:\/\/doi.org\/10.1006\/nbdi.1998.0168","journal-title":"Neurobiol Dis"},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bj\u00f8rk\u00f8y","year":"2005","unstructured":"Bj\u00f8rk\u00f8y G, Lamark T, Brech A, Outzen H, Perander M, \u00d8vervatn A, Stenmark H, Johansen T (2005) p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171:603\u2013614","journal-title":"J Cell Biol"},{"key":"1364_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259. https:\/\/doi.org\/10.1007\/bf00308809","journal-title":"Acta Neuropathol"},{"key":"1364_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"1364_CR7","unstructured":"Brodmann K (1909) Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues. Barth, City"},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0006-8993(84)90735-2","volume":"290","author":"W Caan","year":"1984","unstructured":"Caan W, Perrett DI, Rolls ET (1984) Responses of striatal neurons in the behaving monkey. 2. Visual processing in the caudal neostriatum. Brain Res 290:53\u201365. https:\/\/doi.org\/10.1016\/0006-8993(84)90735-2","journal-title":"Brain Res"},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90:537\u2013548. https:\/\/doi.org\/10.1016\/s0092-8674(00)80513-9","journal-title":"Cell"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/00005072-198809000-00003","volume":"47","author":"SM de la Monte","year":"1988","unstructured":"de la Monte SM, Vonsattel JP, Richardson EP Jr (1988) Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington\u2019s disease. J Neuropathol Exp Neurol 47:516\u2013525","journal-title":"J Neuropathol Exp Neurol"},{"key":"1364_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/biot.200600249","volume":"2","author":"B Dehay","year":"2007","unstructured":"Dehay B, Weber C, Trottier Y, Bertolotti A (2007) Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity. Biotechnol J 2:559\u2013564. https:\/\/doi.org\/10.1002\/biot.200600249","journal-title":"Biotechnol J"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuron.2020.11.005","volume":"109","author":"R Dewan","year":"2021","unstructured":"Dewan R, Chia R, Ding J, Hickman RA, Stein TD, Abramzon Y, Ahmed S, Sabir MS, Portley MK, Tucci A et al (2021) Pathogenic huntingtin repeat expansions in patients with frontotemporal dementia and amyotrophic lateral sclerosis. Neuron 109:448-460.e444. https:\/\/doi.org\/10.1016\/j.neuron.2020.11.005","journal-title":"Neuron"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science (New York, NY) 277:1990\u20131993","journal-title":"Science (New York, NY)"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1523\/JNEUROSCI.17-09-03052.1997","volume":"17","author":"RJ Ferrante","year":"1997","unstructured":"Ferrante RJ, Gutekunst C-A, Persichetti F, McNeil SM, Kowall NW, Gusella JF, MacDonald ME, Beal MF, Hersch SM (1997) Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J Neurosci 17:3052\u20133063","journal-title":"J Neurosci"},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/1531-8249(200101)49:1<29::AID-ANA7>3.0.CO;2-B","volume":"49","author":"E G\u00f3mez-Tortosa","year":"2001","unstructured":"G\u00f3mez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP et al (2001) Quantitative neuropathological changes in presymptomatic Huntington\u2019s disease. Ann Neurol 49:29\u201334","journal-title":"Ann Neurol"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andr\u00e9 VM, Wilburn B, Lu X-H, Tao J, Yamazaki I, Li S-H, Sun YE (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28:6182\u20136195","journal-title":"J Neurosci"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"8710","DOI":"10.1073\/pnas.92.19.8710","volume":"92","author":"C-A Gutekunst","year":"1995","unstructured":"Gutekunst C-A, Levey AI, Heilman CJ, Whaley WL, Yi H, Nash NR, Rees HD, Madden JJ, Hersch SM (1995) Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci 92:8710\u20138714","journal-title":"Proc Natl Acad Sci"},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1523\/jneurosci.19-07-02522.1999","volume":"19","author":"CA Gutekunst","year":"1999","unstructured":"Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D, Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington\u2019s disease: relationship to neuropathology. J Neurosci 19:2522\u20132534. https:\/\/doi.org\/10.1523\/jneurosci.19-07-02522.1999","journal-title":"J Neurosci"},{"key":"1364_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.31887\/DCNS.2016.18.1\/shaber","volume":"18","author":"SN Haber","year":"2016","unstructured":"Haber SN (2016) Corticostriatal circuitry. Dialogues Clin Neurosci 18:7\u201321","journal-title":"Dialogues Clin Neurosci"},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1006\/exnr.1998.6919","volume":"154","author":"GM Halliday","year":"1998","unstructured":"Halliday GM, McRitchie DA, Macdonald V, Double KL, Trent RJ, McCusker E (1998) Regional specificity of brain atrophy in Huntington\u2019s disease. Exp Neurol 154:663\u2013672. https:\/\/doi.org\/10.1006\/exnr.1998.6919","journal-title":"Exp Neurol"},{"key":"1364_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-f","volume":"133","author":"JC Hedreen","year":"1991","unstructured":"Hedreen JC, Peyser CE, Folstein SE, Ross CA (1991) Neuronal loss in layers V and VI of cerebral cortex in Huntington\u2019s disease. Neurosci Lett 133:257\u2013261. https:\/\/doi.org\/10.1016\/0304-3940(91)90583-f","journal-title":"Neurosci Lett"},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s004010051037","volume":"97","author":"H Heinsen","year":"1999","unstructured":"Heinsen H, R\u00fcb U, Bauer M, Ulmar G, Bethke B, Sch\u00fcler M, B\u00f6cker F, Eisenmenger W, G\u00f6tz M, Korr H et al (1999) Nerve cell loss in the thalamic mediodorsal nucleus in Huntington\u2019s disease. Acta Neuropathol 97:613\u2013622. https:\/\/doi.org\/10.1007\/s004010051037","journal-title":"Acta Neuropathol"},{"key":"1364_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s004010050408","volume":"91","author":"H Heinsen","year":"1996","unstructured":"Heinsen H, R\u00fcb U, Gangnus D, Jungkunz G, Bauer M, Ulmar G, Bethke B, Sch\u00fcler M, B\u00f6cker F, Eisenmenger W et al (1996) Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington\u2019s disease. Acta Neuropathol 91:161\u2013168. https:\/\/doi.org\/10.1007\/s004010050408","journal-title":"Acta Neuropathol"},{"key":"1364_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/bf00310376","volume":"88","author":"H Heinsen","year":"1994","unstructured":"Heinsen H, Strik M, Bauer M, Luther K, Ulmar G, Gangnus D, Jungkunz G, Eisenmenger W, G\u00f6tz M (1994) Cortical and striatal neurone number in Huntington\u2019s disease. Acta Neuropathol 88:320\u2013333. https:\/\/doi.org\/10.1007\/bf00310376","journal-title":"Acta Neuropathol"},{"key":"1364_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/NEN.0b013e318198d320","volume":"68","author":"ES Herndon","year":"2009","unstructured":"Herndon ES, Hladik CL, Shang P, Burns DK, Raisanen J, White CL 3rd (2009) Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains. J Neuropathol Exp Neurol 68:250\u2013261. https:\/\/doi.org\/10.1097\/NEN.0b013e318198d320","journal-title":"J Neuropathol Exp Neurol"},{"key":"1364_CR26","unstructured":"Hickman R, Dewan R, Cortes E, Traynor B, Vonsattel J-P (2021) Comorbid neurodegenerative pathologies in brains with huntington disease. J Neuropathol Exp Neurol, pp 560\u2013560"},{"key":"1364_CR27","doi-asserted-by":"crossref","unstructured":"Hickman RA, Dewan R, Cortes E, Traynor BJ, Marder K, Vonsattel J-P (2021) Amyotrophic lateral sclerosis is over-represented in two Huntington\u2019s disease brain bank cohorts: further evidence to support genetic pleiotropy of pathogenic HTT gene expansion. Acta Neuropathol, pp 1\u20134","DOI":"10.1007\/s00401-021-02385-1"},{"key":"1364_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00401-021-02269-4","volume":"141","author":"RA Hickman","year":"2021","unstructured":"Hickman RA, Faust PL, Rosenblum MK, Marder K, Mehler MF, Vonsattel JP (2021) Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains. Acta Neuropathol 141:399\u2013413. https:\/\/doi.org\/10.1007\/s00401-021-02269-4","journal-title":"Acta Neuropathol"},{"key":"1364_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11910-020-01063-1","volume":"20","author":"RA Hickman","year":"2020","unstructured":"Hickman RA, Flowers XE, Wisniewski T (2020) Primary age-related tauopathy (PART): addressing the spectrum of neuronal tauopathic changes in the aging brain. Curr Neurol Neurosci Rep 20:39. https:\/\/doi.org\/10.1007\/s11910-020-01063-1","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1364_CR30","doi-asserted-by":"crossref","unstructured":"Hickman RA, O\u2019Shea SA, Mehler MF, Chung WK (2022) Neurogenetic disorders across the lifespan: from aberrant development to degeneration. Nat Rev Neurol, pp 1\u20138","DOI":"10.1038\/s41582-021-00595-5"},{"key":"1364_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst C-A, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"1364_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/brain\/93.3.525","volume":"93","author":"JM Kemp","year":"1970","unstructured":"Kemp JM, Powell TP (1970) The cortico-striate projection in the monkey. Brain 93:525\u2013546. https:\/\/doi.org\/10.1093\/brain\/93.3.525","journal-title":"Brain"},{"key":"1364_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1098\/rstb.1971.0105","volume":"262","author":"JM Kemp","year":"1971","unstructured":"Kemp JM, Powell TP (1971) The termination of fibres from the cerebral cortex and thalamus upon dendritic spines in the caudate nucleus: a study with the Golgi method. Philos Trans R Soc Lond B Biol Sci 262:429\u2013439. https:\/\/doi.org\/10.1098\/rstb.1971.0105","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1364_CR34","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","volume":"97","author":"S Krobitsch","year":"2000","unstructured":"Krobitsch S, Lindquist S (2000) Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A 97:1589\u20131594. https:\/\/doi.org\/10.1073\/pnas.97.4.1589","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1364_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2990.2007.00884.x","volume":"34","author":"E Kuusisto","year":"2008","unstructured":"Kuusisto E, Kauppinen T, Alafuzoff I (2008) Use of p62\/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol 34:169\u2013180. https:\/\/doi.org\/10.1111\/j.1365-2990.2007.00884.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1364_CR36","doi-asserted-by":"crossref","unstructured":"Landles C, Milton RE, Ali N, Flomen R, Flower M, Schindler F, Gomez-Paredes C, Bondulich MK, Osborne GF, Goodwin D (2020) Subcellular localization and formation of huntingtin aggregates correlates with symptom onset and progression in a Huntington\u2019s disease model. Brain Commun 2: fcaa066","DOI":"10.1093\/braincomms\/fcaa066"},{"key":"1364_CR37","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","volume":"285","author":"C Landles","year":"2010","unstructured":"Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, Sun B, Gafni J, Ellerby LM, Trottier Y (2010) Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 285:8808\u20138823","journal-title":"J Biol Chem"},{"key":"1364_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0022-510X(76)90114-3","volume":"28","author":"H Lange","year":"1976","unstructured":"Lange H, Thorner G, Hopf A, Schroder KF (1976) Morphometric studies of the neuropathological changes in choreatic diseases. J Neurol Sci 28:401\u2013425","journal-title":"J Neurol Sci"},{"key":"1364_CR39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cell.2015.07.003","volume":"162","author":"J-M Lee","year":"2015","unstructured":"Lee J-M, Wheeler VC, Chao MJ, Vonsattel JPG, Pinto RM, Lucente D, Abu-Elneel K, Ramos EM, Mysore JS, Gillis T (2015) Identification of genetic factors that modify clinical onset of Huntington\u2019s disease. Cell 162:516\u2013526","journal-title":"Cell"},{"key":"1364_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ebiom.2018.03.031","volume":"31","author":"JK Lee","year":"2018","unstructured":"Lee JK, Conrad A, Epping E, Mathews K, Magnotta V, Dawson JD, Nopoulos P (2018) Effect of trinucleotide repeats in the huntington\u2019s gene on intelligence. EBioMedicine 31:47\u201353. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.031","journal-title":"EBioMedicine"},{"key":"1364_CR41","doi-asserted-by":"publisher","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","volume":"21","author":"H Li","year":"2001","unstructured":"Li H, Li S-H, Yu Z-X, Shelbourne P, Li X-J (2001) Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington\u2019s disease mice. J Neurosci 21:8473\u20138481","journal-title":"J Neurosci"},{"key":"1364_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/00005072-199902000-00003","volume":"58","author":"ML Maat-Schieman","year":"1999","unstructured":"Maat-Schieman ML, Dorsman JC, Smoor MA, Siesling S, Van Duinen SG, Verschuuren JJ, den Dunnen JT, Van Ommen GJ, Roos RA (1999) Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol 58:129\u2013137. https:\/\/doi.org\/10.1097\/00005072-199902000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"1364_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/JHD-200429","volume":"10","author":"DG Monckton","year":"2021","unstructured":"Monckton DG (2021) The contribution of somatic expansion of the CAG repeat to symptomatic development in Huntington\u2019s disease: a historical perspective. J Huntington\u2019s Dis 10:7\u201333. https:\/\/doi.org\/10.3233\/JHD-200429","journal-title":"J Huntington's Dis"},{"key":"1364_CR44","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/hmg\/ddaa139","volume":"29","author":"R Mouro Pinto","year":"2020","unstructured":"Mouro Pinto R, Arning L, Giordano JV, Razghandi P, Andrew MA, Gillis T, Correia K, Mysore JS, Grote Urtubey DM, Parwez CR et al (2020) Patterns of CAG repeat instability in the central nervous system and periphery in Huntington\u2019s disease and in spinocerebellar ataxia type 1. Hum Mol Genet 29:2551\u20132567. https:\/\/doi.org\/10.1093\/hmg\/ddaa139","journal-title":"Hum Mol Genet"},{"key":"1364_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06281-3","volume":"9","author":"A Neueder","year":"2018","unstructured":"Neueder A, Dumas AA, Benjamin AC, Bates GP (2018) Regulatory mechanisms of incomplete huntingtin mRNA splicing. Nat Commun 9:1\u201313","journal-title":"Nat Commun"},{"key":"1364_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull RL, Tabrizi SJ, Bates GP (2017) The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci Rep 7:1\u201310","journal-title":"Sci Rep"},{"key":"1364_CR47","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1212\/wnl.58.5.695","volume":"58","author":"HD Rosas","year":"2002","unstructured":"Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B (2002) Regional and progressive thinning of the cortical ribbon in Huntington\u2019s disease. Neurology 58:695\u2013701. https:\/\/doi.org\/10.1212\/wnl.58.5.695","journal-title":"Neurology"},{"key":"1364_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"HD Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY, Zaleta AK, Pappu V, Fischl B, Greve D, Hevelone N, Hersch SM (2008) Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain 131:1057\u20131068. https:\/\/doi.org\/10.1093\/brain\/awn025","journal-title":"Brain"},{"key":"1364_CR49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/bpa.12115","volume":"24","author":"U R\u00fcb","year":"2014","unstructured":"R\u00fcb U, Hentschel M, Stratmann K, Brunt E, Heinsen H, Seidel K, Bouzrou M, Auburger G, Paulson H, Vonsattel JP et al (2014) Huntington\u2019s disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem. Brain Pathol 24:247\u2013260. https:\/\/doi.org\/10.1111\/bpa.12115","journal-title":"Brain Pathol"},{"key":"1364_CR50","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","volume":"23","author":"U R\u00fcb","year":"2013","unstructured":"R\u00fcb U, Hoche F, Brunt ER, Heinsen H, Seidel K, Del Turco D, Paulson HL, Bohl J, von Gall C, Vonsattel JP et al (2013) Degeneration of the cerebellum in Huntington\u2019s disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process. Brain Pathol 23:165\u2013177. https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00629.x","journal-title":"Brain Pathol"},{"key":"1364_CR51","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/bpa.12237","volume":"25","author":"U R\u00fcb","year":"2015","unstructured":"R\u00fcb U, Seidel K, Vonsattel JP, Lange HW, Eisenmenger W, Gotz M, Del Turco D, Bouzrou M, Korf HW, Heinsen H (2015) Huntington\u2019s disease (HD): neurodegeneration of Brodmann\u2019s primary visual area 17 (BA17). Brain Pathol 25:701\u2013711. https:\/\/doi.org\/10.1111\/bpa.12237","journal-title":"Brain Pathol"},{"key":"1364_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-19285-7_1","volume":"217","author":"U R\u00fcb","year":"2015","unstructured":"R\u00fcb U, Vonsattel JP, Heinsen H, Korf HW (2015) The Neuropathology of Huntington s disease: classical findings, recent developments and correlation to functional neuroanatomy. Adv Anat Embryol Cell Biol 217:1\u2013146","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"1364_CR53","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RL, Roos RA, Howland D et al (2013) Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A 110:2366\u20132370. https:\/\/doi.org\/10.1073\/pnas.1221891110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1364_CR54","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89:910\u2013926","journal-title":"Neuron"},{"key":"1364_CR55","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, Bates GP, Lehrach H, Wanker EE (1999) Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington\u2019s disease pathology. Proc Natl Acad Sci 96:4604. https:\/\/doi.org\/10.1073\/pnas.96.8.4604","journal-title":"Proc Natl Acad Sci"},{"key":"1364_CR56","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675. https:\/\/doi.org\/10.1038\/nmeth.2089","journal-title":"Nat Methods"},{"key":"1364_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2013.00104","author":"C Seger","year":"2013","unstructured":"Seger C (2013) The visual corticostriatal loop through the tail of the caudate: circuitry and function. Front Syst Neurosci. https:\/\/doi.org\/10.3389\/fnsys.2013.00104","journal-title":"Front Syst Neurosci"},{"key":"1364_CR58","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1212\/wnl.41.7.1117","volume":"41","author":"A Sotrel","year":"1991","unstructured":"Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH (1991) Morphometric analysis of the prefrontal cortex in Huntington\u2019s disease. Neurology 41:1117\u20131123. https:\/\/doi.org\/10.1212\/wnl.41.7.1117","journal-title":"Neurology"},{"key":"1364_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci7100128","author":"T Takeuchi","year":"2017","unstructured":"Takeuchi T, Nagai Y (2017) Protein misfolding and aggregation as a therapeutic target for polyglutamine diseases. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci7100128","journal-title":"Brain Sci"},{"key":"1364_CR60","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/378403a0","volume":"378","author":"Y Trottier","year":"1995","unstructured":"Trottier Y, Lutz Y, Stevanin G, Imbert G, Devys D, Cancel G, Saudou F, Weber C, David G, Tora L et al (1995) Polyglutamine expansion as a pathological epitope in Huntington\u2019s disease and four dominant cerebellar ataxias. Nature 378:403\u2013406. https:\/\/doi.org\/10.1038\/378403a0","journal-title":"Nature"},{"key":"1364_CR61","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00001756-200604240-00022","volume":"17","author":"WM van Roon-Mom","year":"2006","unstructured":"van Roon-Mom WM, Hogg VM, Tippett LJ, Faull RL (2006) Aggregate distribution in frontal and motor cortex in Huntington\u2019s disease brain. NeuroReport 17:667\u2013670. https:\/\/doi.org\/10.1097\/00001756-200604240-00022","journal-title":"NeuroReport"},{"key":"1364_CR62","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-007-0311-9","volume":"115","author":"JP Vonsattel","year":"2008","unstructured":"Vonsattel JP, Del Amaya MP, Keller CE (2008) Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol 115:509\u2013532. https:\/\/doi.org\/10.1007\/s00401-007-0311-9","journal-title":"Acta Neuropathol"},{"key":"1364_CR63","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57:369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"key":"1364_CR64","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"1364_CR65","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1083\/jcb.200710158","volume":"181","author":"C-E Wang","year":"2008","unstructured":"Wang C-E, Zhou H, McGuire JR, Cerullo V, Lee B, Li S-H, Li X-J (2008) Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. J Cell Biol 181:803\u2013816","journal-title":"J Cell Biol"},{"key":"1364_CR66","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.tins.2008.07.004","volume":"31","author":"AJ Williams","year":"2008","unstructured":"Williams AJ, Paulson HL (2008) Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci 31:521\u2013528. https:\/\/doi.org\/10.1016\/j.tins.2008.07.004","journal-title":"Trends Neurosci"},{"key":"1364_CR67","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajmg.b.31232","volume":"156","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS (2011) Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156:751\u2013763. https:\/\/doi.org\/10.1002\/ajmg.b.31232","journal-title":"Am J Med Genet B Neuropsychiatr Genet"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01364-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01364-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T12:04:22Z","timestamp":1650456262000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01364-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01364-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,19]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All brain donors were consented for autopsy and brain donation. All procedures performed were in accordance with the ethical standards of the institution and with the 1964 Helsinki declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}